Impact of population-based or targeted BMD interventions on fracture incidence

被引:0
作者
N. C. Harvey
J. A. Kanis
E. Liu
L. Vandenput
M. Lorentzon
C. Cooper
E. McCloskey
H. Johansson
机构
[1] University of Southampton,MRC Lifecourse Epidemiology Unit
[2] University of Southampton and University Hospital Southampton NHS Foundation Trust,NIHR Southampton Biomedical Research Centre
[3] University of Sheffield,Centre for Metabolic Bone Diseases
[4] Australian Catholic University,Mary McKillop Institute for Health Research
[5] University of Gothenburg,Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy
[6] University of Gothenburg,Geriatric Medicine, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine
[7] Sahlgrenska University Hospital,Geriatric Medicine
[8] University of Oxford,NIHR Oxford Biomedical Research Centre
[9] University of Sheffield,Centre for Integrated research in Musculoskeletal Ageing (CIMA), Mellanby Centre for Bone Research
来源
Osteoporosis International | 2021年 / 32卷
关键词
BMD; Epidemiology; Fracture; Osteoporosis; Population; Targeted;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1973 / 1979
页数:6
相关论文
共 192 条
[1]  
Kanis JA(2007)The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women OsteoporosInt 18 1033-1046
[2]  
Oden A(2010)Osteoporosis: impact on health and economics Nat Rev Rheumatol 6 99-105
[3]  
Johnell O(1994)Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group Osteoporos Int 4 368-381
[4]  
Johansson H(2014)Osteoporosis: a lifecourse approach J Bone Miner Res 29 1917-1925
[5]  
de Laet C(2019)European guidance for the diagnosis and management of osteoporosis in postmenopausal women Osteoporos Int 30 3-44
[6]  
Brown J(2003)A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis Osteoporos Int 14 843-847
[7]  
Burckhardt P(1986)Involutional osteoporosis N Engl J Med 314 1676-1686
[8]  
Cooper C(1999)The use of calcium in the management of osteoporosis Bone 24 279-290
[9]  
Christiansen C(1992)Epidemiology of osteoporosis Trends Endocrinol Metab 3 224-229
[10]  
Cummings S(1996)Rationale and clinical indications for bone density measurements Osteoporos Int 6 Suppl 2 6-8